PD
PDS Biotechnology Corporation
PDSB · NASDAQ
$0.22 +0.00% (+$0.00)
1M -71.62%
Market Cap $12.3M
P/E Ratio -
Div. Yield -
ROE 708.20%
Bulios Fair Price
$0.18
18.2% downside
Trenutna cena
$0.22
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PDSB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 40.54%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 3,550.39%
Asset turnover 0.00x
ROE 708.20%
Debt
5 /100
High Current ratio 0.57x
Int. coverage -4.08x
Debt/Equity N/A
Stability
55 /100
Moderate Beta 1.55x
Profitable years 0
EPS volatility 14.03%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PDSB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Frank K. Bedu-Addo
Employees
21
Headquarters
Princeton
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report